Home » Stocks » NSPX

Inspyr Therapeutics, Inc. (NSPX)

Stock Price: $0.0069 USD -0.0008 (-10.39%)
Updated May 14, 2021 3:54 PM EDT - Market closed
Market Cap 3.48M
Revenue (ttm) n/a
Net Income (ttm) -6.36M
Shares Out 43.34M
EPS (ttm) -0.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $0.0069
Previous Close $0.0077
Change ($) -0.0008
Change (%) -10.39%
Day's Open 0.0083
Day's Range 0.0050 - 0.0084
Day's Volume 8,770,114
52-Week Range 0.0005 - 0.1830

News

Proceeds support the development of lead asset, RT-AR001, an adenosine receptor antagonist Funds were secured from an existing institutional investor WESTLAKE VILLAGE, CA / ACCESSWIRE / January 12, 2021...

4 months ago - Accesswire

About NSPX

Inspyr Therapeutics, Inc., a pharmaceutical company, focuses on the research and development of therapeutics for the treatment of cancer. Its immune-oncology lead asset is RT-AR001, an adenosine A2B receptor antagonist for tumor infiltration. The company was formerly known as GenSpera Inc. and changed its name to Inspyr Therapeutics, Inc. in August 2016. Inspyr Therapeutics, Inc. was incorporated in 2003 and is based in Westlake Village, California.

Industry
Biotechnology
Founded
2003
Stock Exchange
OTCMKTS
Ticker Symbol
NSPX
Full Company Profile

Financial Performance

Financial Statements